YOLANDA PRASSADA: Open Payments
NPI 1811008337 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 29 payments from 9 companies in 2025. Trend: 2023 $614 · 2024 $543 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 5 | $199 |
| Organon LLC | 9 | $143 |
| SHIELD THERAPEUTICS INC | 2 | $137 |
| Astellas Pharma US Inc | 4 | $93 |
| Sumitomo Pharma America, Inc. | 4 | $73 |
| Hologic Sales and Service, LLC | 2 | $44 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| MILLICENT US INC | 1 | $15 |
Products named: NEXPLANON, ACCRUFER, TWIRLA, SLYND, MYFEMBREE, Veozah, Vesicare, APTIMA.
Industry payments across OK — which companies pay providers there.
